NTRK3 and cancer: ETV6-NTRK3 chimeric was a common oncogene fusion in a variety of cancers, including infantile fibrosarcoma (11), acute myeloid leukemia (12), mammary analogue secretory carcinoma (13), congenital mesoblastic nephroma (14), secretory breast carcinoma (15) and radiation-related PTC (16).